Corrigendum to "Studies on the phase I metabolites of the new designer drug 1-(2, 3-dihydro-1H-inden-5-yl)-2(pyrrolidine-1-yl)butan-1-one (5-PPDI) in human urine" Forensic Sci. Int. 310 (2020) 110214. (March 2023)